SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-323807
Filing Date
2018-11-09
Accepted
2018-11-09 16:28:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d631218ds3.htm S-3 331736
2 EX-1.2 d631218dex12.htm EX-1.2 195181
3 EX-4.1 d631218dex41.htm EX-4.1 371533
4 EX-5.1 d631218dex51.htm EX-5.1 20981
5 EX-5.2 d631218dex52.htm EX-5.2 4431
6 EX-23.3 d631218dex233.htm EX-23.3 1883
7 GRAPHIC g631218g17x87.jpg GRAPHIC 38365
  Complete submission text file 0001193125-18-323807.txt   979927
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228319 | Film No.: 181173454
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1